Lexpos News

Owners of 10 or more pharmacies are being invited to become observers to the Community Pharmacy England Committee, as an interim measure while the Committee begins work on permanent changes. Community Pharmacy England has written to all community pharmacy owners with 10 or more pharmacy premises in England (the non-CCA multiple category) to offer them [...]

The post Community Pharmacy England invites non-CCA multiples to join its Committee appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined the September 2024 concessionary price for Metformin 500mg modified-release tablets: Drug Pack size Price concession Metformin 500mg modified-release tablets 56 £3.26 (previously £2.00) The improved price will apply to prescriptions submitted for [...]

The post Improved price concession for Metformin 500mg modified-release tablets for September 2024 appeared first on Community Pharmacy England.

The Prime Minister was asked at PMQs today what the Government is doing to improve access to General Practice. In his answer, Sir Keir Starmer said: “We are going to expand the role of community pharmacies and accelerate the roll-out of independent prescribing. We need much more care to be delivered in local communities to [...]

The post Prime Minister speaks positively about Community Pharmacy during PMQs appeared first on Community Pharmacy England.

Community pharmacy owners are invited to share data to inform an important fiscal review of the sector. Frontier Economics and IQVIA have been commissioned to carry out an economic analysis of community pharmacy on behalf of NHS England. This includes understanding the full economic costs of delivering NHS pharmaceutical services and how these costs vary, [...]

The post Economic analysis: How much does it cost to run a pharmacy? appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Trandate® (labetalol) 50mg tablets MSN/2024/101 Tier 2 medium impact Date of issue: 7th October 2024 Trandate® (labetalol) 50mg tablets will be discontinued from July 2025. Alternative low dose beta-blockers remain available. Where these are not suitable, UK manufactured Specials of labetalol [...]

The post Medicine Supply Notification: Trandate® (labetalol) 50mg tablets appeared first on Community Pharmacy England.